Navigating Rare Disease
June 2, 2026 · Toronto
Explore how rare disease teams can deliver more relevant, personalised engagement across increasingly complex patient and stakeholder journeys.
Steve Walters is a pharmaceutical commercial intelligence leader with over 12 years of experience spanning industry and entrepreneurship. He spent much of his career at Pfizer in a commercial roles, contributing to the launch of seven drugs across multiple therapeutic areas.
In 2025, he founded Inpharmativ Consulting to help small and mid-sized biotech and pharma companies make smarter commercial decisions through KOL mapping, physician targeting, competitive intelligence, and AI/LLM brand visibility audits. Steve also brings a rare perspective as a rare disease patient, writing for IG Living Magazine, publishing The Zebra Pulse newsletter, and contributing to CORD and Immunity Canada.
